Investing Ideas
/
Swedish Pharmaceuticals & Biotech High Growth Potential Companies

Header cover image

Swedish Pharmaceuticals & Biotech High Growth Potential Companies

UPDATED Mar 17, 2024

Companies with a Future performance score of at least 3, ordered by Future performance score.

33 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	SECARE Swedencare	kr62.66	3.5%	143.7%	kr9.9b	kr68.00	PE169.7x	E50.4%	0.4%
	SPRINT Sprint Bioscience	kr1.17	29.2%	137.8%	kr81.3m	kr3.20	PS1.6x	S34.0%	n/a
	SCOL Scandion Oncology	kr2.15	-4.9%	-4.5%	kr87.3m	kr3.20	PB1.9x	E59.8%	n/a
	FLUO FluoGuide	kr54.00	12.3%	-46.0%	kr658.7m	kr141.94	PS1028.7x	E36.5%	n/a
	CANTA Cantargia	kr2.69	0.6%	-58.3%	kr493.7m	kr12.67	PB2.9x	E65.3%	n/a
	BIOG B BioGaia	kr127.50	2.7%	38.3%	kr12.9b	kr140.00	PE35.2x	E8.9%	5.4%
	AMNI Amniotics	kr0.0026	8.3%	-99.0%	kr7.1m	n/a	PB0.5x	E84.5%	n/a
	BIOT Biotage	kr176.10	-4.4%	32.4%	kr14.2b	kr186.67	PE57.7x	E18.0%	0.9%
	LIPUM Lipum	kr6.66	1.5%	-33.1%	kr62.0m	kr20.00	PB13.6x	E74.9%	n/a

Page 2 of 2